RecallDepth
Class II Ongoing

Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0

This recall is currently active, issued April 14, 2021. It was issued by Apotex Corp..

Company
Apotex Corp.
Recall Initiated
March 31, 2021
Posted
April 14, 2021
Recall Number
D-0324-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
55620 bottles
Firm Location
Weston, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: RX1662, RX1663, RX1664 Exp. 11/2022

More recalls by Apotex Corp.

View all recalls by this company →

Other recent Class II Drug recalls